REM sleep behavior disorder is a parasomnia in which the skeletal muscle atonia that normally accompanies REM sleep fails, so that the motor programmes generated during dreaming are executed rather than suppressed. Patients punch, kick, shout, and leap from bed, frequently injuring themselves or a bed partner, and wake alert with matching dream recall. Diagnosis requires both the behavioural history and polysomnographic demonstration of REM sleep without atonia. What makes the disorder important beyond its immediate injury risk is what it signifies: in older adults the isolated (idiopathic) form is not idiopathic at all but the earliest clinically detectable stage of an alpha-synuclein neurodegenerative disease. Post-mortem series find Lewy body disease in the overwhelming majority, with alpha-synuclein deposited in precisely the brainstem structures that regulate REM atonia, and prospective follow-up shows conversion to Parkinson disease, dementia with Lewy bodies, or multiple system atrophy at about 6% per year, reaching roughly three-quarters by twelve years. That combination - a specific, polysomnographically verifiable marker with a decade-long lead time over an overt neurodegenerative syndrome - makes it the most powerful prodromal state available in neurodegeneration, and the population in which disease-modifying trials are most feasible.
Ask a research question about REM Sleep Behavior Disorder. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
name: REM Sleep Behavior Disorder
creation_date: "2026-08-24T00:00:00Z"
category: Neurological Disorder
parents:
- Sleep Disorder
- Neurological Disease
disease_term:
preferred_term: REM sleep behavior disorder
term:
id: MONDO:0005937
label: REM sleep behavior disorder
description: >-
REM sleep behavior disorder is a parasomnia in which the skeletal muscle
atonia that normally accompanies REM sleep fails, so that the motor programmes
generated during dreaming are executed rather than suppressed. Patients punch,
kick, shout, and leap from bed, frequently injuring themselves or a bed
partner, and wake alert with matching dream recall. Diagnosis requires both
the behavioural history and polysomnographic demonstration of REM sleep
without atonia. What makes the disorder important beyond its immediate injury
risk is what it signifies: in older adults the isolated (idiopathic) form is
not idiopathic at all but the earliest clinically detectable stage of an
alpha-synuclein neurodegenerative disease. Post-mortem series find Lewy body
disease in the overwhelming majority, with alpha-synuclein deposited in
precisely the brainstem structures that regulate REM atonia, and prospective
follow-up shows conversion to Parkinson disease, dementia with Lewy bodies, or
multiple system atrophy at about 6% per year, reaching roughly three-quarters
by twelve years. That combination - a specific, polysomnographically
verifiable marker with a decade-long lead time over an overt neurodegenerative
syndrome - makes it the most powerful prodromal state available in
neurodegeneration, and the population in which disease-modifying trials are
most feasible.
notes: >-
SCOPE. This entry covers REM sleep behavior disorder as an entity, spanning
the isolated form and the symptomatic forms (antidepressant-associated,
narcolepsy type 1-associated, and that occurring in established
synucleinopathy). The isolated form's prodromal significance is curated as a
consequence of the degenerative aetiology, not of the syndrome, so the
antidepressant-associated presentation does not inherit it - see the module's
open discussion on whether the two routes are genuinely separable.
DIFFERENTIAL DISCIPLINE. Nocturnal motor behaviour is not this disorder. NREM
parasomnias arise from incomplete arousal out of slow-wave sleep, typically in
the first third of the night, with confusion and no dream recall; sleep-related
hypermotor (nocturnal frontal lobe) epilepsy produces stereotyped, brief,
clustered events. Both occur with an entirely intact REM-atonia circuit. This
is why the polysomnographic criterion is not a formality: without it the
entity dissolves into "things people do at night".
pathophysiology:
- name: Alpha-Synuclein Pathology in the Brainstem REM-Atonia Circuit
description: >-
The trigger in the common, age-related form. Alpha-synuclein aggregates and
associated neuronal loss and gliosis involve the pontomedullary structures
that generate REM atonia - the subcoeruleus nucleus (the human homologue of
the rodent sublaterodorsal nucleus), the gigantocellular reticular nucleus,
and the laterodorsal tegmentum - at a stage when nigrostriatal and cortical
structures are still relatively spared. The anatomical specificity is the
point: this is not incidental pathology in a diffusely affected brain but
involvement of the exact circuit whose failure the syndrome expresses, which
is what licenses reading the parasomnia as a topographically early stage of
the disease rather than as an associated feature. Alternative triggers
substitute at this node: a structural pontine lesion, the state instability
of narcolepsy type 1, or serotonergic/noradrenergic antidepressant exposure.
role: trigger
biological_scale: CELLULAR
conforms_to: "rem_sleep_atonia_control_failure#Lesion of the Pontine REM-Atonia Generator"
cell_types:
- preferred_term: neuron of the subcoeruleus and pontomedullary REM-atonia circuit
term:
id: CL:0000540
label: neuron
modifier: DECREASED
locations:
- preferred_term: pons
term:
id: UBERON:0000988
label: pons
- preferred_term: brainstem
term:
id: UBERON:0002298
label: brainstem
evidence:
- reference: PMID:39577924
reference_title: "Post-mortem neuropathology of idiopathic rapid eye movement sleep behaviour disorder: a case series."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In all participants, α-synuclein was found in the structures that regulate
REM sleep atonia (eg, subcoeruleus nucleus, gigantocellular reticular
nucleus, laterodorsal tegmentum, and amygdala).
explanation: >-
Direct post-mortem demonstration, in every case examined, that the
pathology sits in the specific atonia-regulating structures - the
anatomical specificity this node asserts.
- reference: PMID:39577924
reference_title: "Post-mortem neuropathology of idiopathic rapid eye movement sleep behaviour disorder: a case series."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Post-mortem neuropathological diagnoses were Lewy body disease in 19 (95%)
and multiple system atrophy (MSA) in one (5%).
explanation: >-
Establishes that the underlying pathology is a synucleinopathy in
essentially all cases coming to autopsy, which is the basis for curating
the degenerative aetiology as the principal trigger.
- reference: PMID:17412731
reference_title: Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Neuroimaging data from the few published human cases with RBD associated
with structural lesions in the brainstem are presented, in which the dorsal
midbrain and pons are implicated.
explanation: >-
The lesional substitution at this node - a discrete structural lesion at
the same site reproduces the syndrome, which is what makes the location
rather than the pathology the causal factor.
downstream:
- target: Loss of Descending Drive to Inhibitory Premotor Neurons
description: >-
Loss of the REM-on population removes the excitatory drive its descending
axons carry to medullary and spinal inhibitory premotor neurons.
causal_link_type: DIRECT
- name: Loss of Descending Drive to Inhibitory Premotor Neurons
description: >-
REM atonia is actively imposed rather than passively permitted: glutamatergic
REM-on neurons excite glycinergic and GABAergic premotor neurons in the
ventromedial medulla and spinal cord, which hyperpolarise skeletal motor
neurons. Losing the descending drive releases motor neurons from an inhibition
that should be present. The critical anatomical fact is that this descending
pathway is separate from the ascending pathway generating the EEG features of
REM sleep - so atonia can be lost while REM sleep itself proceeds entirely
normally, which is exactly what polysomnography shows in these patients.
role: amplifier
biological_scale: CELLULAR
conforms_to: "rem_sleep_atonia_control_failure#Loss of Descending Glutamatergic Drive to Inhibitory Premotor Neurons"
biological_processes:
- preferred_term: glutamatergic synaptic transmission
term:
id: GO:0035249
label: synaptic transmission, glutamatergic
modifier: DECREASED
locations:
- preferred_term: brainstem
term:
id: UBERON:0002298
label: brainstem
evidence:
- reference: PMID:17884926
reference_title: "The pontine REM switch: past and present."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
In the REM-on area are two populations of glutamatergic neurons, the first
of which projects to the basal forebrain and regulates EEG components of
REM sleep and the second of which projects to the ventromedial medulla and
spinal cord and regulates atonia during REM sleep.
explanation: >-
Establishes the two-population anatomy on which this node and the
dissociation below it depend.
- reference: PMID:17884926
reference_title: "The pontine REM switch: past and present."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Our findings demonstrating independent pathways mediating atonia and the
EEG components of REM provide a basis for their occasional dissociation in
pathological states, e.g. REM sleep behaviour disorder.
explanation: >-
Names this disorder as the pathological instance of the dissociation,
which is the mechanistic claim of the entry.
downstream:
- target: REM Sleep Without Atonia
description: >-
Without descending excitation of the inhibitory premotor pool, skeletal
motor neurons are not hyperpolarised during REM sleep and muscle tone
persists.
causal_link_type: DIRECT
- name: REM Sleep Without Atonia
description: >-
The central, measurable abnormality: excess tonic or phasic electromyographic
activity scored during REM sleep. It is graded rather than binary, and its
magnitude carries prognostic weight - quantified atonia loss is among the
significant predictors of phenoconversion. It is also separable from the
clinical behaviours: population screening finds isolated REM sleep without
atonia roughly nine times more often than full disorder, which suggests it is
the earlier and more sensitive marker of the same process, though whether
every case progresses is unknown.
role: central_effector
biological_scale: ORGANISM
conforms_to: "rem_sleep_atonia_control_failure#Failure of REM Sleep Skeletal Muscle Atonia"
biological_processes:
- preferred_term: REM sleep
term:
id: GO:0042747
label: circadian sleep/wake cycle, REM sleep
modifier: ABNORMAL
- preferred_term: skeletal muscle contraction during REM sleep
term:
id: GO:0003009
label: skeletal muscle contraction
modifier: INCREASED
evidence:
- reference: PMID:30166532
reference_title: REM sleep behaviour disorder.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
A clinical history of dream enactment or complex motor behaviours together
with the presence of muscle activity during REM sleep confirmed by video
polysomnography are mandatory for a definite RBD diagnosis.
explanation: >-
Establishes the measurement standard for this node and that it is
mandatory rather than supportive.
- reference: PMID:37816644
reference_title: "REM Sleep Behavior Disorder and Its Possible Prodromes in General Population: Prevalence, Polysomnography Findings, and Associated Factors."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Sex and DEB frequency-adjusted prevalence of RBD was 1.4% (95% CI
1.0%-1.8%), isolated RWA was 12.5% (95% CI 11.3%-13.6%), and isolated DEB
was 3.4% (95% CI 2.7%-4.1%).
explanation: >-
Quantifies the dissociation this node describes: isolated REM sleep
without atonia is roughly nine times commoner in the population than the
full disorder.
downstream:
- target: Dream Enactment Behaviour
description: >-
With motor neurons no longer inhibited, the motor programmes generated
during REM dreaming are executed.
causal_link_type: DIRECT
- name: Dream Enactment Behaviour
description: >-
Released motor output takes the form of behaviour matched to dream content -
the observation that ties the syndrome to REM physiology rather than to a
nonspecific motor release. Because dream content in this population is
disproportionately confrontational, the behaviours are frequently violent,
and injury to the patient or bed partner is the presenting problem. Unlike an
NREM parasomnia the episodes are not preceded by confusional arousal, and the
patient wakes alert with dream recall that matches the observed behaviour.
role: effector
biological_scale: ORGANISM
conforms_to: "rem_sleep_atonia_control_failure#Motor Enactment of Dream Content During REM Sleep"
biological_processes:
- preferred_term: muscle contraction
term:
id: GO:0006936
label: muscle contraction
modifier: INCREASED
evidence:
- reference: PMID:17412731
reference_title: Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
REM sleep behaviour disorder (RBD) is a parasomnia characterized by the
loss of normal skeletal muscle atonia during REM sleep with prominent motor
activity accompanying dreaming.
explanation: >-
Links the released motor activity specifically to dreaming, which is what
distinguishes this node from a generic nocturnal motor phenomenon.
downstream:
- target: Sleep-Related Injury
description: >-
Violent enacted behaviour causes injury to the patient and bed partner.
causal_link_type: DIRECT
- target: Progression to Overt Synucleinopathy
description: >-
Where the trigger is degenerative, the same alpha-synuclein pathology
spreads beyond the brainstem to nigral and cortical structures. This edge
does not apply to the antidepressant-associated or purely lesional forms.
causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
- name: Sleep-Related Injury
description: >-
The immediate consequence, and the one management addresses: bruising,
lacerations, fractures, subdural haematoma, and injury to the bed partner.
Environmental safety measures - removing bedside weapons and hard objects,
padding, sleeping separately in severe uncontrolled cases - are graded as a
good-practice statement necessary for appropriate management, ahead of any
drug recommendation, which is an unusual ordering and reflects that the
modifiable risk here is mechanical rather than pharmacological.
role: consequence
biological_scale: ORGANISM
evidence:
- reference: PMID:36515157
reference_title: "Management of REM sleep behavior disorder: an American Academy of Sleep Medicine clinical practice guideline."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
It is critically important to help patients maintain a safe sleeping
environment to prevent potentially injurious nocturnal behaviors.
explanation: >-
The guideline's good-practice statement, which establishes injury
prevention as the primary management objective at this node.
- name: Progression to Overt Synucleinopathy
description: >-
The second consequence, of a different kind and applying only to the
degenerative route. The brainstem pathology spreads to involve nigral and
limbic-cortical structures, and the patient converts to Parkinson disease,
dementia with Lewy bodies, or multiple system atrophy. Conversion runs at
about 6.3% per year, reaching 73.5% by twelve years - high, but neither
immediate nor universal, and the distinction matters when counselling. The
post-mortem series adds a topographic dimension worth preserving: those who
remained free of another neurological disorder, or who developed Parkinson
disease without dementia, had alpha-synuclein largely confined to brainstem
and limbic system with few coexisting pathologies, whereas those who
developed dementia had diffuse cortical involvement and frequent comorbid
Alzheimer pathology - so the destination, not just the timing, tracks the
extent of spread.
role: consequence
biological_scale: ORGANISM
evidence:
- reference: PMID:30789229
reference_title: "Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The overall conversion rate from iRBD to an overt neurodegenerative
syndrome was 6.3% per year, with 73.5% converting after 12-year follow-up.
explanation: >-
Quantifies the conversion risk in a 1280-patient multicentre cohort, which
is what allows this node to state a rate rather than an association.
- reference: PMID:39577924
reference_title: "Post-mortem neuropathology of idiopathic rapid eye movement sleep behaviour disorder: a case series."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In individuals with IRBD without any other neurological disorder and in
those who developed Parkinson's disease without dementia, α-synuclein was
found in the brainstem and limbic system and rarely in the cortex, whereas
coexisting proteinopathies were few and showed mild pathological burden.
explanation: >-
Supports the topographic claim in the node description - that the clinical
destination tracks the anatomical extent of spread, not merely its
duration.
- reference: PMID:39577924
reference_title: "Post-mortem neuropathology of idiopathic rapid eye movement sleep behaviour disorder: a case series."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Concomitant pathologies are frequent and their role remains to be
clarified: some might have contributed to the development of dementia, but
some might be age-related changes.
explanation: >-
Cited as PARTIAL because it withholds the causal reading of the comorbid
pathologies rather than supporting it - the association with dementia is
observed, its causal contribution explicitly not established.
phenotypes:
- category: Neurological
name: Dream Enactment Behaviour
description: >-
Complex, often violent motor behaviour during REM sleep, matched to dream
content, with alert waking and dream recall.
phenotype_term:
preferred_term: REM sleep behavior disorder
term:
id: HP:5200291
label: REM sleep behavior disorder
temporality: RECURRENT
frequency: OBLIGATE
evidence:
- reference: PMID:30166532
reference_title: REM sleep behaviour disorder.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
abnormal behaviours occurring during REM sleep, often as dream enactments
that can cause injury
explanation: >-
OBLIGATE by definition rather than by observation: dream enactment history
is a mandatory diagnostic criterion, so every diagnosed patient has it.
- category: Neurological
name: REM Sleep Without Atonia
description: >-
Excess tonic or phasic submental (with or without limb) electromyographic
activity during scored REM sleep on video polysomnography.
phenotype_term:
preferred_term: Abnormal rapid eye movement sleep
term:
id: HP:0002494
label: Abnormal rapid eye movement sleep
frequency: OBLIGATE
evidence:
- reference: PMID:30166532
reference_title: REM sleep behaviour disorder.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
characterized by loss of muscle atonia during REM sleep (known as REM sleep
without atonia, or RSWA)
explanation: >-
OBLIGATE by definition: polysomnographic REM sleep without atonia is a
mandatory criterion for definite diagnosis.
- category: Neurological
name: Sleep-Related Injury
description: >-
Injury to the patient or bed partner resulting from enacted behaviour;
lacerations, bruising, fractures and falls from bed.
phenotype_term:
preferred_term: Abnormal movement during sleep
term:
id: HP:5200300
label: Abnormal movement during sleep
evidence:
- reference: PMID:36515157
reference_title: "Management of REM sleep behavior disorder: an American Academy of Sleep Medicine clinical practice guideline."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
the removal of bedside weapons, or objects that could inflict injury if
thrown or wielded against a bed partner, is of paramount importance
explanation: >-
Supports injury as a recognised and management-relevant consequence; no
frequency band is asserted, since the guideline does not quantify it.
diagnosis:
- name: Video polysomnography with quantified REM atonia scoring
description: >-
The mandatory diagnostic test, and the only one that establishes the entity.
Submental (with or without limb) electromyographic activity is scored during
REM sleep, and simultaneous video captures the behaviours. "Any" EMG activity
at a threshold around 22% performs best against clinical diagnosis in
population screening. Screening questionnaires are not adequate substitutes:
a positive RBD screening questionnaire had good specificity but a positive
predictive value under 8% in the general population, meaning over twelve in
thirteen screen-positive people do not have the disorder.
evidence:
- reference: PMID:37816644
reference_title: "REM Sleep Behavior Disorder and Its Possible Prodromes in General Population: Prevalence, Polysomnography Findings, and Associated Factors."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Among the RWA parameters, any EMG activity showed the best association with
the RBD and its possible prodromes (area under the curve, 0.917).
explanation: >-
Identifies the best-performing polysomnographic parameter for this
diagnosis.
- reference: PMID:37816644
reference_title: "REM Sleep Behavior Disorder and Its Possible Prodromes in General Population: Prevalence, Polysomnography Findings, and Associated Factors."
supports: REFUTE
evidence_source: HUMAN_CLINICAL
snippet: >-
RBDSQ score of ≥5 had good specificity but poor positive predictive value
(PPV) for RBD (specificity 84.1% and PPV 7.7%)
explanation: >-
Cited as REFUTE against the use of questionnaire screening as a
substitute for polysomnography at population level, which is the practical
point this diagnostic entry makes.
treatments:
- name: Sleep Environment Safety Measures
description: >-
Removal of bedside weapons and injury-capable objects, padding of sharp
furniture and headboard, soft floor covering beside the bed, and separate
sleeping arrangements in severe uncontrolled cases. Graded as a good-practice
statement whose implementation is necessary for appropriate management -
that is, ahead of any pharmacological recommendation in the guideline's own
ordering. It addresses the injury consequence directly and has no mechanistic
action, which is precisely why it is the most reliably effective
intervention available.
therapeutic_modality: BEHAVIORAL
treatment_term:
preferred_term: Supportive Care
term:
id: NCIT:C15747
label: Supportive Care
target_mechanisms:
- target: Sleep-Related Injury
treatment_effect: INHIBITS
description: >-
Removes the physical means of injury without altering the released motor
behaviour, acting on the consequence rather than on any upstream node.
evidence:
- reference: PMID:36515157
reference_title: "Management of REM sleep behavior disorder: an American Academy of Sleep Medicine clinical practice guideline."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The following good practice statement is based on expert consensus, and its
implementation is necessary for the appropriate and effective management of
patients with RBD
explanation: >-
Records both the recommendation and its evidence basis (expert consensus),
and its placement ahead of the graded drug recommendations.
- name: Clonazepam
description: >-
Low-dose benzodiazepine that suppresses the enacted behaviours. It acts on
the behavioural effector node and is not disease-modifying; the AASM
recommendation is conditional. Sedation, falls and cognitive effects are
material concerns in a population that is by definition in a
neurodegenerative prodrome.
therapeutic_modality: SMALL_MOLECULE
treatment_term:
preferred_term: Pharmacotherapy
term:
id: NCIT:C15986
label: Pharmacotherapy
therapeutic_agent:
- preferred_term: clonazepam
term:
id: CHEBI:3756
label: clonazepam
target_mechanisms:
- target: Dream Enactment Behaviour
treatment_effect: INHIBITS
description: >-
Suppresses released motor behaviour without restoring REM atonia or
altering the underlying pathology.
evidence:
- reference: PMID:36515157
reference_title: "Management of REM sleep behavior disorder: an American Academy of Sleep Medicine clinical practice guideline."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The AASM suggests that clinicians use clonazepam (vs no treatment) for the
treatment of isolated RBD in adults. (CONDITIONAL).
explanation: >-
Cited as PARTIAL because the guideline's own strength assignment is
conditional rather than strong.
- name: Immediate-Release Melatonin
description: >-
The alternative symptomatic agent, generally preferred where sedation, falls,
or cognitive impairment make a benzodiazepine unattractive. Also a
conditional recommendation, and also acting on the behavioural node rather
than on the pathology.
therapeutic_modality: SMALL_MOLECULE
treatment_term:
preferred_term: Pharmacotherapy
term:
id: NCIT:C15986
label: Pharmacotherapy
therapeutic_agent:
- preferred_term: melatonin
term:
id: CHEBI:16796
label: melatonin
target_mechanisms:
- target: Dream Enactment Behaviour
treatment_effect: INHIBITS
description: >-
Reduces frequency and intensity of enacted behaviours; not shown to restore
REM atonia or to alter progression.
evidence:
- reference: PMID:36515157
reference_title: "Management of REM sleep behavior disorder: an American Academy of Sleep Medicine clinical practice guideline."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The AASM suggests that clinicians use immediate-release melatonin (vs no
treatment) for the treatment of isolated RBD in adults. (CONDITIONAL).
explanation: >-
Cited as PARTIAL for the same reason as clonazepam: a conditional
recommendation, so neither agent may be curated as established therapy.
prevalence:
- population: Korean population-based cohort aged 50-80, home polysomnography confirmed
measure_type: POINT_PREVALENCE
prevalence_class: ABOVE_1_IN_1000
rate_per_100000: 1400.0
rate_low: 1000.0
rate_high: 1800.0
notes: >-
Polysomnography-confirmed prevalence in adults aged 50-80. Consistent with
other recent population-based estimates of 1.18-1.34%. Isolated REM sleep
without atonia, the presumed prodrome, was roughly nine times commoner at
12.5%.
evidence:
- reference: PMID:37816644
reference_title: "REM Sleep Behavior Disorder and Its Possible Prodromes in General Population: Prevalence, Polysomnography Findings, and Associated Factors."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Sex and DEB frequency-adjusted prevalence of RBD was 1.4% (95% CI
1.0%-1.8%), isolated RWA was 12.5% (95% CI 11.3%-13.6%)
explanation: >-
Gives the adjusted point prevalence and confidence interval directly, and
the prodromal-state figure quoted in the note.
- reference: PMID:37816644
reference_title: "REM Sleep Behavior Disorder and Its Possible Prodromes in General Population: Prevalence, Polysomnography Findings, and Associated Factors."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The prevalence of polysomnography (PSG)–confirmed RBD is suggested at
1.18%–1.34%, based on recent population-based studies.
explanation: >-
Corroborates the estimate against other population-based series, which is
what the note refers to.
classifications:
harrisons_chapter:
- classification_value: NEUROLOGIC
evidence:
- reference: PMID:30166532
reference_title: REM sleep behaviour disorder.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Rapid eye movement (REM) sleep behaviour disorder (RBD) is a parasomnia
that is characterized by loss of muscle atonia during REM sleep
explanation: >-
A parasomnia of brainstem origin, classified under the nervous-system
chapter, the schema having no dedicated sleep chapter.
discussions:
- discussion_id: gap_neuroprotection_trial_window
kind: KNOWLEDGE_GAP
prompt: >-
Can the decade-long prodromal window in this disorder be used to demonstrate
neuroprotection, and what endpoint would show it?
attaches_to:
- pathophysiology#Progression to Overt Synucleinopathy
rationale: >-
This entry describes the most favourable setting neurodegeneration offers for
a disease-modifying trial: an objectively verifiable marker, a defined
at-risk population, a conversion rate high enough to power a trial (142-366
patients per arm on published estimates), and roughly a decade of lead time
before overt disease. Nothing has been shown to alter that trajectory, and
the obstacle is partly an endpoint problem. Phenoconversion is a clinical
diagnosis made years downstream and is a coarse, late outcome; the entry's
own central node (quantified atonia loss) is closer to the pathology but its
relationship to progression elsewhere in the brain is itself unresolved.
Whether a shorter-term biological endpoint can substitute determines whether
trials in this population are feasible at all.
proposed_experiments:
- experiment_id: exp_rbd_surrogate_endpoint_validation
name: Validation of short-term progression markers against phenoconversion
description: >-
In an existing multicentre isolated-REM-sleep-behavior-disorder cohort with
long follow-up, test candidate short-horizon markers - seed-amplification
assay alpha-synuclein status, serial dopamine-transporter imaging,
quantitative atonia loss, olfactory and autonomic measures - against
observed phenoconversion, to establish whether any change over two to three
years predicts the clinical endpoint well enough to serve as a trial
outcome.
- discussion_id: gap_isolated_rwa_natural_history
kind: KNOWLEDGE_GAP
prompt: >-
Does isolated REM sleep without atonia, nine times commoner than the full
disorder, carry the same prodromal meaning?
attaches_to:
- pathophysiology#REM Sleep Without Atonia
rationale: >-
Population screening finds isolated REM sleep without atonia in 12.5% of
adults aged 50-80, against 1.4% with the full disorder. If that finding
carried the same phenoconversion risk, it would imply a prodromal
synucleinopathy population an order of magnitude larger than currently
recognised - which is either a major public-health observation or evidence
that the polysomnographic marker is far less specific than its use as a
mandatory criterion assumes. The entry curates the two as separable for that
reason, and the question is directly answerable by follow-up rather than
requiring new methods.
proposed_experiments:
- experiment_id: exp_isolated_rwa_prospective_followup
name: Prospective follow-up of population-ascertained isolated atonia loss
description: >-
Long-term prospective surveillance of population-screened individuals with
isolated REM sleep without atonia, isolated dream enactment, and neither,
with incident parkinsonism and dementia as outcomes, to establish whether
the polysomnographic marker alone confers the risk attached to the full
syndrome.